Blog: Disrupting the Emerging Cancer Crisis in Africa
Through partnerships and collaboration, AAI is mobilizing resources to aid African health systems to meet growing needs and cure more patients, despite the challenges posed by the increasing burden of cancer.
Blog: Global Cancer Research Investments Are Not Reaching Africa – How the African Access Initiative Is Changing the Trend.
BVGH analyses have revealed comparatively limited investment in cancer research at African organizations, which likely contributes to Africa’s substantial cancer disparities.
ecancer Interview at the Global Health Catalyst Summit
Jennifer Dent sits down with ecancer at the 2019 Global Health Catalyst Summit to discuss how AAI is making inroads in AAI partner countries.
Article: “Shifting Africa’s Cancer Narrative from Despair to Hope”
The Biden Cancer Initiative’s blog — Pulse on Progress — featured an article on how BVGH’s African Access Initiative is working to reverse cancer morality patterns on the African continent.
Blog: “We’ve reached an important milestone in addressing cancer in the U.S. – but success should not end there.”
We must take the lessons and strategies learned battling cancer in the U.S. and apply them on a larger scale. Global cancer trends are imbalanced. It is time for us to share our successes and create change.
STAT News Article: “Patients of African descent are being denied the benefits of cancer breakthroughs. We’re changing that.”
Death rates from cancer are falling and access to potentially lifesaving treatments is increasing — except among Africans and Americans of African descent. This gap must be closed.
BVGH’s African Access Initiative featured at the Biden Cancer Summit
BVGH was featured at the Biden Cancer Summit, hosted by Vice President Joe Biden and Dr. Jill Biden, for its commitment to addressing Africa’s long under-recognized cancer epidemic through the African Access Initiative.
Video: BVGH presents AAI at Biden Cancer Summit
BVGH has launched the African Access Initiative in partnership with leading pharmaceutical companies, Pfizer and Takeda Pharmaceuticals, and is also working with five African ministries of health including Nigeria, Kenya, Côte d’Ivoire, Cameroon, and Rwanda.
Press Release: “Nigerian Federal Ministry of Health to Launch Pilot Cancer Drug Access Program with BVGH”
“Collaborating with BVGH and leading academic and industry partners, including Memorial Sloan Kettering Cancer Center, Pfizer, and Takeda, is critical for saving Nigerian cancer patients’ lives,” said Nigeria’s Honorable Minister of Health, Professor Isaac Adewole
WIPO Re:Search Partnership Stories 2016-2019
In this publication, BVGH brings to life the WIPO Re:Search portfolio of 155 R&D collaborations focused on improving the prevention, diagnosis, and treatment of some of the world’s most-devastating diseases. The stories show how global cross-sector collaborations are driving R&D for neglected infectious diseases.
WIPO Re:Search: Advancing Product Development for Neglected Infectious Diseases through Global Public-Private Partnerships
This publication highlights seven exciting drug development collaborations that are advancing solutions to some of the world’s most pernicious diseases. Each featured collaboration has achieved key R&D milestones and has been advanced and de-risked through WIPO Re:Search.
TropMed Special Edition Book – Prospects for Schistosomiasis Elimination
The Journal of Tropical Medicine and Infectious Disease has published their special edition on schistosomiasis, featuring a BVGH peer-reviewed publication: “WIPO Re:Search—A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis.”
TropMed Article: “WIPO Re:Search – Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development”
Through case studies, this article illustrates how WIPO Re:Search empowers high-quality tropical disease drug discovery researchers to leapfrog their R&D programs by accessing pharmaceutical industry resources.
TropMed Article: “WIPO Re:Search – A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis”
Using WIPO Re:Search as an example, this article highlights the opportunities for the public-private partnership model to play a key role in the elimination of schistosomiasis.
Book Chapter: “Creating, Managing, and Advancing Collaborations: The Road to Successful Partnerships”
BVGH authored chapter in “The Cambridge Handbook of Private-Public Partnerships, Intellectual Property Governance, and Sustainable Development. The full open-access book can be found on Seattle University’s Digital Commons here.
Access to Medicines Foundation Article: “How to accelerate pharmaceutical R&D – A new framework for sharing IP with global health researchers”
In collaboration with BVGH, the Access to Medicine Foundation has now developed a new framework for evaluating industry IP-sharing agreements for R&D. The framework will be used for the first time as part of the 2018 Access to Medicine Index analysis.